APO RESEARCH · REPORT
Estriol
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
Product & engineering
Understand the product.
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
Selected research
Market Structure
Global Estriol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
The leading producers in the sector are Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, with revenues of 28.20 percent, 13.44 percent and 21.48 percent respectively in 2019.
This report provides an overview of the global Estriol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Estriol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Estriol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Estriol market size, projected growth trends, production technologies, key applications, and end-use industries.
Estriol Segment by Company
Jiangxi Yuneng Pharmaceutical
Shanghai Lianlu Industry
Jiangsu Yuanda SYM Pharmaceutical
Estriol Segment by Type
Purity: <99%
Purity: ≥99%
Estriol Segment by Application
Pharmaceutical
Biological Research
Estriol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estriol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Estriol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estriol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Estriol market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Estriol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Estriol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Estriol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity: <99%
- Purity: ≥99%
Applications
- Pharmaceutical
- Biological Research
Companies covered
- Jiangxi Yuneng Pharmaceutical
- Shanghai Lianlu Industry
- Jiangsu Yuanda SYM Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Estriol Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Estriol Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Estriol Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Estriol Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Estriol Market Dynamics
- 2.1 Estriol Industry Trends
- 2.2 Estriol Industry Drivers
- 2.3 Estriol Industry Opportunities and Challenges
- 2.4 Estriol Industry Restraints
3 Estriol Market by Manufacturers
- 3.1 Global Estriol Revenue by Manufacturers (2021-2026)
- 3.2 Global Estriol Sales by Manufacturers (2021-2026)
- 3.3 Global Estriol Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Estriol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Estriol Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Estriol Manufacturers, Product Type & Application
- 3.7 Global Estriol Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Estriol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Estriol Players Market Share by Revenue in 2025
- 3.8.3 2025 Estriol Tier 1, Tier 2, and Tier 3
4 Estriol Market by Type
- 4.1 Estriol Type Introduction
- 4.1.1 Purity: <99%
- 4.1.2 Purity: ≥99%
- 4.2 Global Estriol Sales by Type
- 4.2.1 Global Estriol Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Estriol Sales by Type (2021-2032)
- 4.2.3 Global Estriol Sales Market Share by Type (2021-2032)
- 4.3 Global Estriol Revenue by Type
- 4.3.1 Global Estriol Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Estriol Revenue by Type (2021-2032)
- 4.3.3 Global Estriol Revenue Market Share by Type (2021-2032)
5 Estriol Market by Application
- 5.1 Estriol Application Introduction
- 5.1.1 Pharmaceutical
- 5.1.2 Biological Research
- 5.2 Global Estriol Sales by Application
- 5.2.1 Global Estriol Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Estriol Sales by Application (2021-2032)
- 5.2.3 Global Estriol Sales Market Share by Application (2021-2032)
- 5.3 Global Estriol Revenue by Application
- 5.3.1 Global Estriol Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Estriol Revenue by Application (2021-2032)
- 5.3.3 Global Estriol Revenue Market Share by Application (2021-2032)
6 Global Estriol Sales by Region
- 6.1 Global Estriol Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Estriol Sales by Region (2021-2032)
- 6.2.1 Global Estriol Sales by Region (2021-2026)
- 6.2.2 Global Estriol Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Estriol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Estriol Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Estriol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Estriol Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Estriol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Estriol Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Estriol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Estriol Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Estriol Revenue by Region
- 7.1 Global Estriol Revenue by Region
- 7.1.1 Global Estriol Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Estriol Revenue by Region (2021-2026)
- 7.1.3 Global Estriol Revenue by Region (2027-2032)
- 7.1.4 Global Estriol Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Estriol Revenue (2021-2032)
- 7.2.2 North America Estriol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Estriol Revenue (2021-2032)
- 7.3.2 Europe Estriol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Estriol Revenue (2021-2032)
- 7.4.2 Asia-Pacific Estriol Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Estriol Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Estriol Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Jiangxi Yuneng Pharmaceutical
- 8.1.1 Jiangxi Yuneng Pharmaceutical Company Information
- 8.1.2 Jiangxi Yuneng Pharmaceutical Business Overview
- 8.1.3 Jiangxi Yuneng Pharmaceutical Estriol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Jiangxi Yuneng Pharmaceutical Estriol Product Portfolio
- 8.1.5 Jiangxi Yuneng Pharmaceutical Recent Developments
- 8.2 Shanghai Lianlu Industry
- 8.2.1 Shanghai Lianlu Industry Company Information
- 8.2.2 Shanghai Lianlu Industry Business Overview
- 8.2.3 Shanghai Lianlu Industry Estriol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shanghai Lianlu Industry Estriol Product Portfolio
- 8.2.5 Shanghai Lianlu Industry Recent Developments
- 8.3 Jiangsu Yuanda SYM Pharmaceutical
- 8.3.1 Jiangsu Yuanda SYM Pharmaceutical Company Information
- 8.3.2 Jiangsu Yuanda SYM Pharmaceutical Business Overview
- 8.3.3 Jiangsu Yuanda SYM Pharmaceutical Estriol Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangsu Yuanda SYM Pharmaceutical Estriol Product Portfolio
- 8.3.5 Jiangsu Yuanda SYM Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Estriol Value Chain Analysis
- 9.1.1 Estriol Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Estriol Production Mode & Process
- 9.2 Estriol Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Estriol Distributors
- 9.2.3 Estriol Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst